Tela Bio Inc Reports Results For The Quarter Ended In December: Earnings Summary

TELA Bio

21/03/2023 21:01

* TELA Bio Inc  TELA.OQ  reported a quarterly adjusted loss
of 52
cents​​ per share for the quarter ended in December. The mean
expectation of five analysts for the quarter was for a loss
of 55 cents per share.
    * Revenue rose 38.8% to $11.62 million from a year ago;
analysts
expected $13.19 million. 
    * TELA Bio Inc's reported EPS for the quarter was a loss
of 52
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * TELA Bio Inc shares had fallen by 9.2% this quarter.
    * The company reported a quarterly loss of $9.98 million.
    * Wall Street's median 12-month price target for TELA Bio
Inc is
$17.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 21 at 09:00 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.55          -0.52          Beat
 Sep. 30 2022      -0.63          -0.64          Missed
 Jun. 30 2022      -0.62          -0.79          Missed
 Mar. 31 2022      -0.56          -0.75          Missed